Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

RCS-01 cell therapy is safe and improves skin gene expression.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Preparing and learning about menopause can improve women's quality of life as they approach this phase.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

Combining Anu Taila Nasya and Gokshura Lepa may help reduce hair loss and promote regrowth.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Women generally want more hair volume, which becomes a concern around menopause due to hair loss.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.